Lymphadenectomy in Early Ovarian Cancer

To assess the impact of comprehensive staging surgery with no lymphadenectomy on survival and quality of life in patients with early-stage ovarian cancer.

Trial Details

NCT ID
NCT04710797
Phase
NA
Sponsor
Sun Yat-sen University
Status
RECRUITING
Cancer Type
Ovarian Cancer
Interventions
  • Completion staging surgery including systematic pelvic and para-aortic lymphadenectomy
  • Comprehensive staging surgery with no Lymphadenectomy
Locations (sample)
  • Guangzhou, Guangdong, China|23.11667,113.25

Key Eligibility Criteria

  • Women aged 18 years to 70 years.
  • Primary diagnosis of epithelial ovarian cancer FIGO stage IA-IIA ( recevive no prior treatment or receive incomplete initial surgery),with indicati…
  • Patients who have given their signed and written informed consent.
  • Good performance status (ECOG 0/1).

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Ovarian Cancer Trials on Trialify →